Last updated: September 21, 2022
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Allergy
Allergy (Pediatric)
Common Cold
Treatment
N/AClinical Study ID
NCT05553483
P.T.REC/012/003341
Ages 12-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- allergic rhinitis children
- physician-based diagnosis of allergic rhinitis
Exclusion
Exclusion Criteria:
- children with intellectual disabilities
- chest disease or heart disease or local congenital nose deformities
- participants received within-previous-six-months self-prescribed or by-therapistprescribed complementary therapies
Study Design
Total Participants: 60
Study Start date:
September 15, 2021
Estimated Completion Date:
December 01, 2022
Study Description
Connect with a study center
Cairo Unoversity
Giza,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.